ZNF228 can be understood through their interactions with various cellular signaling pathways and biochemical mechanisms. For instance, the direct activation of adenylyl cyclase by Forskolin leads to an increase in intracellular cAMP levels. This elevation in cAMP can activate protein kinase A (PKA), which in turn may phosphorylate and activate transcription factors such as CREB. Activated CREB can then bind to cAMP response elements within the genome, facilitating the transcription of genes including those that may encode ZNF228 or proteins that regulate ZNF228 activity. Similarly, Isoproterenol, a beta-adrenergic agonist, enhances cAMP production via adenylyl cyclase activation, following a parallel route to potentially activate ZNF228. Additionally, Dibutyryl-cAMP, a synthetic analog of cAMP, bypasses cell surface receptors and directly activates cAMP-dependent pathways, providing another route to ZNF228 activation.
Ionomycin, by acting as a calcium ionophore, increases the intracellular concentration of calcium, a secondary messenger that activates numerous calcium-dependent kinases and phosphatases, which may influence the activity of ZNF228. Bay K8644 also raises intracellular calcium by acting as an L-type calcium channel agonist, triggering calcium-mediated signaling pathways that can lead to the activation of ZNF228. Furthermore, PMA activates protein kinase C (PKC), a family of enzymes that can phosphorylate a wide range of target proteins, potentially leading to altered activity of transcription factors that regulate ZNF228. Anisomycin, through its inhibition of protein synthesis, can activate stress-activated protein kinases like JNK, which may indirectly lead to the activation of transcriptional regulators associated with ZNF228 activity. The chemical activators that influence chromatin structure and gene expression, such as 5-Azacytidine and the histone deacetylase inhibitors Trichostatin A and Valproic acid, can remodel chromatin to a state that is more conducive to transcription factor binding and gene activation, thereby facilitating a cellular environment that supports the activation of ZNF228. Retinoic acid, through its interaction with retinoic acid receptors, can affect gene expression patterns that may include genes regulating or interacting with ZNF228.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin directly activates adenylyl cyclase, increasing intracellular cAMP levels, which could lead to the activation of ZNF228 through cAMP response element-binding protein (CREB) mediated transcriptional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin acts as a calcium ionophore, raising intracellular calcium levels which can activate calcium-dependent signaling pathways, potentially leading to the activation of ZNF228 as calcium signaling is often linked to transcription factor activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which may phosphorylate and activate transcription factors or other regulatory proteins that could lead to ZNF228 activation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist which increases cAMP levels by activating adenylyl cyclase, potentially resulting in the activation of ZNF228 via cAMP-mediated signaling pathways. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor, which may lead to changes in chromatin structure and gene expression, potentially creating a permissive state for ZNF228 activation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor which can alter chromatin structure and enhance transcription factor access to DNA, possibly facilitating ZNF228 activation. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid (VPA) is also a histone deacetylase inhibitor, which may promote a transcriptionally active chromatin state, possibly contributing to ZNF228 activation. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $82.00 $192.00 $801.00 | ||
Bay K8644 acts as an L-type calcium channel agonist, leading to increased intracellular calcium levels, which may activate downstream pathways that lead to ZNF228 activation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Dibutyryl-cAMP is a membrane-permeable cAMP analog that directly elevates cAMP levels, potentially leading to activation of ZNF228 through cAMP-dependent pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid modulates gene expression through its receptors which could lead to a change in the transcriptional regulation environment, potentially promoting ZNF228 activation. | ||||||